Cover Image
Read Now

Ulipristal versus levonorgestrel for emergency contraception a review of comparative cost-effectiveness

A previous CADTH report reviewed the comparative clinical effectiveness and guidelines on the emergency contraception (EC) use of ulipristal acetate versus levonorgestrel. The aim of this report is to review the comparative cost-effectiveness of those two EC drugs

Bibliographic Details
Main Authors: Tran, Khai, Grobelna, Aleksandra (Author)
Corporate Authors: Canadian Agency for Drugs and Technologies in Health Rapid Response Service, Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa CADTH 2019, February 12, 2019
Edition:Version 1.0
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Canada
Contraceptives, Postcoital / Economics
Norpregnadienes
Cost-benefit Analysis
Norgestrel
Contraceptives, Postcoital / Therapeutic Use
Contraception, Postcoital / Economics
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:A previous CADTH report reviewed the comparative clinical effectiveness and guidelines on the emergency contraception (EC) use of ulipristal acetate versus levonorgestrel. The aim of this report is to review the comparative cost-effectiveness of those two EC drugs
Physical Description:1 PDF file (x pages) illustrations

Similar Items